RNA |
Cell-SELEX |
HER-2-overexpressing breast cancer |
94.6 |
[43] |
DNA |
Cell-SELEX |
Acute myeloid leukemia cells |
5.4 ± 1.6 |
[35] |
RNA |
Cell-SELEX |
Mouse embryonic stem cells |
- |
[54] |
DNA |
Cell-SELEX |
Human hepatocarcinoma |
19–450 |
[55] |
RNA |
Cell-SELEX |
AC133-epitope of CD133 expressed on HEK293T cells |
33.85–145 |
[34] |
DNA |
Cell-SELEX |
Over-expressing epidermal growth factor receptor variant III on human glioblastoma |
≤100 |
[56] |
DNA |
on-chip Cell-SELEX |
Different histologically classified ovarian cancer cells |
1.3 |
[57] |
DNA |
Cell-SELEX |
Epidermal growth factor receptor variant III on Glioblastoma |
3.37 ± 0.98 |
[58] |
DNA |
Cell-SELEX |
Metastatic colorectal cell |
8.1 ± 0.9 |
[59] |
DNA |
Cell-SELEX |
Prostate cancer cells |
73.59 ± 11.01 |
[60] |
RNA |
Cell-SELEX |
Annexin A2 |
10.5 ± 4.6 |
[61] |
DNA |
Cell-SELEX By flow cytometry |
3T3-L1 adipocytes cells |
33.1 ± 2.9 |
[62] |
RNA |
Cell-SELEX |
PC3-prostate cancer cell |
71.57 ± 12.96 |
[63] |
DNA |
Cell-SELEX |
Human hepatoma cells HepG2 |
64–349 |
[64] |
DNA |
On-chip Cell-SELEX |
Colorectal cancer cells |
12.3 |
[65] |
DNA |
Cell-SELEX |
Hepatocellular carcinoma |
9.4 ± 2.0 |
[66] |
DNA |
Cell internalization SELEX |
MCF10CA1h human breast ductal carcinoma |
|
[67] |
DNA |
Cell-SELEX |
Nasopharyngeal carcinoma cell lines |
11.93 ± 1.40 |
[68] |
DNA |
Cell-SELEX |
Renal cell carcinoma (768-O) |
9.4 ± 2.0 |
[69] |
DNA |
Cell-SELEX |
Metastatic colorectal carcinoma LOVO cells |
167.3 ± 30.2 |
[70] |